WallStSmart

National Health Investors Inc (NHI)vsVentas Inc (VTR)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 1373% more annual revenue ($6.42B vs $435.78M). NHI leads profitability with a 38.3% profit margin vs 4.1%. NHI appears more attractively valued with a PEG of 4.76. NHI earns a higher WallStSmart Score of 72/100 (B).

NHI

Strong Buy

72

out of 100

Grade: B

Growth: 9.3Profit: 8.0Value: 6.0Quality: 3.5
Piotroski: 3/9Altman Z: 0.98

VTR

Hold

41

out of 100

Grade: D

Growth: 6.0Profit: 4.5Value: 2.7Quality: 4.0
Piotroski: 4/9Altman Z: 0.43
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NHIUndervalued (+33.8%)

Margin of Safety

+33.8%

Fair Value

$133.31

Current Price

$65.68

$67.63 discount

UndervaluedFair: $133.31Overvalued
VTROvervalued (-13.2%)

Margin of Safety

-13.2%

Fair Value

$76.66

Current Price

$83.71

$7.05 premium

UndervaluedFair: $76.66Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NHI5 strengths · Avg: 9.2/10
Profit MarginProfitability
38.3%10/10

Keeps 38 of every $100 in revenue as profit

Operating MarginProfitability
41.1%10/10

Strong operational efficiency at 41.1%

Revenue GrowthGrowth
33.8%10/10

Revenue surging 33.8% year-over-year

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

EPS GrowthGrowth
45.2%8/10

Earnings expanding 45.2% YoY

VTR2 strengths · Avg: 8.0/10
Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.7%8/10

Revenue surging 21.7% year-over-year

Areas to Watch

NHI3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.762/10

Expensive relative to growth rate

Altman Z-ScoreHealth
0.982/10

Distress zone — elevated risk

VTR4 concerns · Avg: 2.5/10
Return on EquityProfitability
1.8%3/10

ROE of 1.8% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

PEG RatioValuation
4.942/10

Expensive relative to growth rate

P/E RatioValuation
159.0x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : NHI

The strongest argument for NHI centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 38.3% and operating margin at 41.1%. Revenue growth of 33.8% demonstrates continued momentum.

Bull Case : VTR

The strongest argument for VTR centers on Price/Book, Revenue Growth. Revenue growth of 21.7% demonstrates continued momentum.

Bear Case : NHI

The primary concerns for NHI are Piotroski F-Score, PEG Ratio, Altman Z-Score.

Bear Case : VTR

The primary concerns for VTR are Return on Equity, Profit Margin, PEG Ratio. A P/E of 159.0x leaves little room for execution misses. Thin 4.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

VTR carries more volatility with a beta of 0.74 — expect wider price swings.

NHI is growing revenue faster at 33.8% — sustainability is the question.

NHI generates stronger free cash flow (63M), providing more financial flexibility.

Monitor REIT - HEALTHCARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NHI scores higher overall (72/100 vs 41/100), backed by strong 38.3% margins and 33.8% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

National Health Investors Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in the sale and leaseback, joint ventures, mortgages, and interim financing of discretionary and medical-based home and investment investments. in needs.

Visit Website →

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Want to dig deeper into these stocks?